Related Experiment Video
Updated: May 21, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular
Weijun Pan1, Van N Pham, Amber N Stratman
1Program in Genomics of Differentiation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
Abstract:
Understanding the mechanisms that regulate angiogenesis and translating these into effective therapies are of enormous scientific and clinical interests. In this report, we demonstrate the central role of CDP-diacylglycerol synthetase (CDS) in the regulation of VEGFA signaling and angiogenesis. CDS activity maintains phosphoinositide 4,5 bisphosphate (PIP2) availability through resynthesis of phosphoinositides, whereas VEGFA, mainly through phospholipase Cγ1, consumes PIP2 for signal transduction. Loss of CDS2, 1 of 2 vertebrate CDS enzymes, results in vascular-specific defects in zebrafish in vivo and failure of VEGFA-induced angiogenesis in endothelial cells in vitro. Absence of CDS2 also results in reduced arterial differentiation and reduced angiogenic signaling. CDS2 deficit-caused phenotypes can be successfully rescued by artificial elevation of PIP2 levels, and excess PIP2 or increased CDS2 activity can promote excess angiogenesis. These results suggest that availability of CDS-controlled resynthesis of phosphoinositides is essential for angiogenesis.
Insights
CDP-diacylglycerol synthetase (CDS) is crucial for blood vessel formation (angiogenesis). It regulates VEGFA signaling by maintaining phosphoinositide 4,5 bisphosphate (PIP2) levels, essential for new blood vessel growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Developmental Biology
Background:
- Angiogenesis, the formation of new blood vessels, is vital for development and disease.
- VEGF (Vascular Endothelial Growth Factor) signaling is a key regulator of angiogenesis.
- Phosphoinositide 4,5 bisphosphate (PIP2) is a critical second messenger in cellular signaling pathways.
Purpose of the Study:
- To investigate the role of CDP-diacylglycerol synthetase (CDS) in regulating VEGFA signaling and angiogenesis.
- To elucidate the mechanism by which CDS influences PIP2 availability and its impact on endothelial cell function.
Main Methods:
- Zebrafish model system for in vivo vascular development studies.
- In vitro endothelial cell culture to assess VEGFA-induced angiogenesis.
- Genetic manipulation of CDS2 expression and phosphoinositide levels.
Main Results:
- Loss of CDS2 in zebrafish caused vascular defects and impaired VEGFA-induced angiogenesis in vitro.
- CDS2 deficiency led to reduced arterial differentiation and angiogenic signaling.
- Restoration of PIP2 levels or increased CDS2 activity rescued defects and promoted angiogenesis.
Conclusions:
- CDS activity is essential for maintaining PIP2 homeostasis, which is critical for VEGFA-mediated angiogenesis.
- CDS acts as a central regulator of angiogenic signaling by controlling phosphoinositide availability.
- Targeting CDS or PIP2 metabolism may offer novel therapeutic strategies for angiogenesis-related disorders.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
IP3/DAG Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Amplifying Signals via Enzymatic Cascade
Hedgehog Signaling Pathway
Mechanism of Angiogenesis

